Given the way in which they have talked up the value of the...

First 6 Last

Share
Profile

Follow
sailnyssa

336 Posts.

10

12/09/18

15:42

Post #: 35552849
Share

Originally posted by doubledeckerdog ↑

Very interesting Base man!

I was unaware that the oncology assets had been taken off the market?

How did you come to that conclusion may I ask?

If you are right, I think that would not not because Merck wants those assets, but rather that nobody wants to buy them and announcing a "No Sale" would be a very bad look for the CEO and the Board.

So, rather than announce a deal that would disappoint the market, they may have decided to delay any announcements until after the PTSD trial results are released - and the shares are running - and then make that (low sale price) announcement late on a Friday afternoon and hope nobody notices in all the PTSD excitement.

My issue here is that they have been trying to flog these assets for over a year and there appears no progress. Given the hype surrounding each of them, this raises a question of whether teh CEO and management have really "gilded the lilly" all along about these assets..........

In the time that they have been trying to flog these assets they have run down their cash and basically have no net cash. Yes, I know they keep telling us thatthey have cash in the bank - but they conveniently fail to mention the borrowings that essentially offset the cash in the bank.

Money in the bank, w--k, w--k, w--k.

As I have said here before, companies in this space should absolutely NOT be doing research or trials using borrowed money. So expect a cap raise sooner rather than later. And we had all better hope that PTSD trials are wildly positive and not just a borderline outcome............

A capital raising or - as you suggest - a low ball takeover offer in the near term are both quite plausible.

I can almost see the future: another mismanaged Aussie biotech getting taken over on the cheap because the Board and management are too smart by half.

I am or am at risk of being genuinely disappointed.

By the way, I would be disappointed even if the takeover was at $1.50.

But that is just me.............given the high expectations I originally held for Bionomics to become a leading global drug discovery company owned and based in Australia.

Cheers and GLTA.

Expand

Given the way in which they have talked up the value of the oncology assets in the past, the company should have made an announcement if these are no longer on the market. On the subject of a cap raise, that should not be necessary if PTSD results are truly positive. Any thoughts DDD as to how long before we get top line PTSD results? ---- GLTAH

BNO Price at posting: 53.0¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

C1X

iTech inks deal with Chilean lithium giant to progress Reynolds Range

ASX Market Open: Aussie market to leap on best 'Trump trade' bump since election day | November 22, 2024

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

PCL

HotCopper users react as Pancontinental Energy's trading halt lift reveals little

CMB

Asian Battery Metals uncover second massive sulphide discovery at Mongolia's Oval play

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

CAF

IP anomaly thrills Cannidah with project extension hopes in QLD

ALY

Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech

There are more pages in this discussion • 23 more messages in this thread...

First 6 Last

Add BNO (ASX) to my watchlist

Given the way in which they have talked up the value of the...

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

iTech inks deal with Chilean lithium giant to progress Reynolds Range

ASX Market Open: Aussie market to leap on best 'Trump trade' bump since election day | November 22, 2024

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

HotCopper users react as Pancontinental Energy's trading halt lift reveals little

Asian Battery Metals uncover second massive sulphide discovery at Mongolia's Oval play

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

IP anomaly thrills Cannidah with project extension hopes in QLD

Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech

Featured News